1. Barry III H, Krimmer EC (1976) Discriminative ?9-tetrahydrocannabinol stimulus tested with several doses, routes, intervals and a marihuana extract. In: Braude MC, Szara S (eds) The pharmacology of marihuana. Raven, New York, pp 535?538
2. Binder M (1982) Zum Wirkungsmechanismus von ?1-Tetrahydrocannabinol, dem psychotropen Prinzip von Haschisch und Marihuana. Funkt Biol Med 1: 199?207
3. Binder M, Edery H, Porath G (1979) 182-3, a non-psychotropic cannabinoid: structure-activity considerations in the cannabinoid series. In: Nahas GG, Paton WDM (eds) Advances in the biosciences, vols 22, 23: Marihuana: Biological effects. Pergamon Press, Oxford New York, pp 71?80
4. Binder M, Franke I (1982) Is there a THC receptor? Current perspectives and approaches to the elucidation of the molecular mechanism of action of the psychotropic constituents of Cannabis sativa L. In: Hucho F (ed) Neuroreceptors. Walter de Gruyter, Berlin New York, pp 151?161
5. Binder M, Witteler FJ, Schmidt B, Franke I, Bohnenberger E, Sandermann H Jr (1984) Triglyceride/phospholipid partitioning and pharmacokinetics of some natural and semi-synthetic cannabinoids: Further evidence for the involvement of specific receptors in the mediation of the psychotropic effects of ?1-Tetrahydrocannabinol and ?6-Tetrahydrocannabinol. In: Agurell S, Dewey WL, Willette RE (eds) The cannabinoids: chemical, pharmacologic and therapeutic aspects. Academic Press, New York London, pp 689?708